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“Every pregnant woman shall be offered HIV testing by her attending physician at her first prenatal visit 
and in the third trimester.  The attending physician shall test the pregnant woman for HIV infection, 
unless the pregnant woman refuses to provide informed consent pursuant to G.S. 130A-148(h).  If there is 
no record at labor and delivery of an HIV test result during the current pregnancy for the pregnant 
woman, the attending physician shall inform the pregnant woman that an HIV test will be performed, 
explain the reasons for testing, and the woman shall be tested for HIV without consent using a rapid HIV 
test unless it reasonably appears that the test cannot be performed without endangering the safety of the 
pregnant woman or the person administering the test.  If the pregnant woman cannot be tested, an existing 
specimen, if one exists that was collected within the last 24 hours, shall be tested using a rapid HIV 
test.  The attending physician must provide the woman with the test results as soon as possible.  However, 
labor and delivery providers who do not currently have the capacity to perform rapid HIV testing are not 
































































































HIV Testing Practices at Labor and Delivery
Thank  you  for  taking  the  time  to  complete  this  survey  on  HIV  Testing  Practices  at  Labor  and  Delivery.  We  are  interested  in  learning  more  about  
how  facilities  determine  if  women  at  Labor  and  Delivery  should  be  tested  for  HIV.  The  results  from  this  survey  will  be  used  to  develop  an  
understanding  of  HIV  testing  practices  at  North  Carolina  Labor  and  Delivery  facilities.    
  
Your  participation  in  this  survey  is  completely  voluntary  and  confidential.  There  are  no  anticipated  risks  from  your  participation  in  this  survey.  All  
data  obtained  from  this  survey  will  be  reported  for  analysis  only.  The  only  person  who  will  have  access  to  these  data  is  the  investigator.  
  
This  survey  should  only  take  about  5-­10  minutes  of  your  time.    
  
This  survey  is  the  final  step  towards  completion  of  an  MPH  degree.  If  you  have  any  questions  about  the  survey,  please  contact  Christy  Crowley  at  
ccrowley@email.unc.edu  or  404-­966-­1464.  
  
In  order  to  progress  through  this  survey,  please  use  the  following  navigation  buttons:  
  
Click  the  Next  button  to  continue  to  the  next  page.  
Click  the  Previous  button  to  return  to  the  previous  page.  
Click  the  Exit  the  Survey  Early  button  if  you  need  to  exit  the  survey.  
Click  the  Submit  button  to  submit  your  survey.  



































HIV Testing Practices at Labor and Delivery
2. How long have you been in your current job position at your facility?
3. When a woman presents at your facility for Labor and Delivery, how often is her 
outpatient prenatal record (for those who received prenatal care) available for review?
4. When a woman presents at your facility for Labor and Delivery, if her prenatal record 
is available, is the record reviewed to determine if she had an HIV test during THIS 
pregnancy?
5. Do you feel there are any consistent barriers to having previous HIV testing history 








Less  then  6  months
  

Greater  than  6  months,  but  less  than  1  year
  

Greater  than  1  year,  but  less  than  2  years
  

Greater  than  2  years,  but  less  than  5  years
  















































HIV Testing Practices at Labor and Delivery
6. What are some consistent barriers to having previous HIV testing history for THIS 
pregnancy immediately available for a woman who presents for Labor and Delivery? 
(Check all that apply)
7. At your facility, what is considered to be sufficient documentation that an HIV test was 
performed during THIS pregnancy?
8. Does your facility have a staff member summarize a woman's prenatal record using a 
checklist / abstract that summarizes a woman's prenatal record and is given to the 
attending OB for Labor and Delivery?
4. Prenatal Records
*
HIV  test  results  not  documented  in  the  prenatal  record
  

Prenatal  records  not  transferred  to  Labor  and  Delivery
  

Prenatal  records  are  received  but  difficult  to  access  in  Labor  and  Delivery
  

Prenatal  records  not  always  available  on  nights  or  weekends
  

Prenatal  record  not  available  for  transport  patient
  

No  electronic  access  to  prenatal  records
  

Prenatal  record  not  legible
  







HIV  test  noted  in  prenatal  records  (no  copy  of  lab  results  available)
  

Copy  of  laboratory  results  included  with  prenatal  record
  
























HIV Testing Practices at Labor and Delivery
9. If your facility does not use a checklist / abstract to summarize a woman's prenatal 
record, is there another method by which her information is provided to the attending OB 
for Labor and Delivery?
10. What other method is used to provide the information from a woman's prenatal 
record to the attending OB for Labor and Delivery?
  
11. Who is responsible for completing this checklist / abstract / other method at your 
facility? (Check all that apply)
12. Does this checklist / abstract / other method indicate whether the woman had an HIV 














































HIV Testing Practices at Labor and Delivery
13. If no documentation is available to confirm a previous HIV test during THIS 
pregnancy, is an HIV test administered?
14. If an HIV test is administered for a woman at Labor and Delivery, when would the HIV 
test be administered? (Check all that apply)
15. If an HIV test is administered for a woman at Labor and Delivery, where is the HIV test 








































In  the  hospital  laboratory
  

At  an  offsite  laboratory
  














HIV Testing Practices at Labor and Delivery
16. In hours, what is the normal amount of time until HIV test results are available for an 
HIV test administered at Labor and Delivery?
17. What are the reasons why an HIV test would not be administered, if no 
documentation is available that confirms a previous HIV test? (Check all that apply)
18. Does your facility have specific policies or procedures to refer women who test HIV 




Less  than  1  hour
  

Greater  than  1  hour,  but  less  than  3  hours
  

Greater  than  3  hours,  but  less  than  6  hours
  

Greater  than  6  hours,  but  less  than  12  hours
  

Greater  than  12  hours,  but  less  than  24  hours
  







Inadequate  time  to  perform  test  prior  to  delivery
  

Inadequate  time  to  receive  test  results  prior  to  delivery
  

Patient  does  not  have  risk  factors  for  HIV
  

Patient  does  not  consent  to  HIV  test
  

HIV  testing  not  standard  facility  practice
  

Point  of  Care  /  Rapid  testing  not  available
  























HIV Testing Practices at Labor and Delivery
19. Does your facility have specific policies or procedures to refer HIV-­exposed newborns 
to a physician with expertise in treating pediatric HIV disease?
20. If your facility refers HIV+ women or HIV-­exposed newborns to a physician with 
expertise in treating HIV disease, where is this physician located?
21. Does your facility have a policy that describes the procedures required at Labor and 
Delivery to determine if a woman has been tested for HIV during THIS pregnancy?

















Duke  University  Medical  Center
  

ECU  /  Vidant  Health  Care
  

UNC  /  New  Hanover  Health  Center
  


































All pregnant women should be screened for human immunodeficiency virus (HIV) infection as early 
as possible during each pregnancy. Human immunodeficiency virus screening should occur after the 
patient is notified that the screening is recommended for all pregnant women and that she will 
receive the test as part of the routine panel of prenatal tests unless she declines (opt-out screening). 
Pregnant women should be provided with oral or written information about HIV that includes an 
explanation of HIV infection, a description of interventions that can reduce HIV transmission from 
mother to infant, the meanings of positive test results and negative test results, and the opportunity 
to ask questions and decline testing. No additional process or written documentation of informed 
consent, beyond what is required for other routine prenatal tests, is required for HIV testing, unless 
state legal requirements necessitate additional documentation. A repeat test in the third trimester is 
recommended for women at high risk of acquiring HIV; however, some states require a repeat test 
later in pregnancy for all pregnant women. Obstetrician–gynecologists should be aware of and comply 
with their states’ legal requirements for perinatal HIV screening. Legal requirements for perinatal HIV 
testing may be verified by contacting state or local public health departments or at www.nccc.ucsf.edu 
(also see Resources). If a patient declines HIV testing, it should be documented in the medical record 
and should not affect access to care. She also should be reoffered testing at a subsequent visit.
When notifying pregnant patients about HIV screening in states using opt-out screening, obstetric 
providers may find it helpful to preface the conversation with the following suggested script:
Physician Script on  
Perinatal HIV Screening
“I test all my pregnant patients for HIV as part of the panel of routine tests to 
alert me to any conditions that require regular attention or treatment to promote 
the best possible outcome in pregnancy. You also may need a repeat HIV test in 
the third trimester. This patient information, HIV and Other Important Pregnancy 
Tests, will explain the importance of each test. When you have finished reading this 
information, I would be glad to answer any questions you have. You will be tested for 
HIV today unless you tell me not to.”
(see reverse)
AA349          12345/54321
Appendix 2
To assist obstetric providers with prenatal HIV screening, the American College of Obstetricians 
and Gynecologists offers a Patient Education Pamphlet, HIV and Pregnancy, and the enclosed HIV 
and Other Important Pregnancy Tests, a convenient-to-use tear pad describing in simple language 
the recommended blood tests for all pregnant women. This tear pad also answers frequently asked 
questions about HIV testing, treatment, and risks for exposed babies. Obstetric providers may use the 
tear pad to help notify pregnant women about HIV testing, but used alone, the information in the tear 
pad may not meet informed consent requirements in individual states. 
Resources
The American College of Obstetricians and Gynecologists




HIV web site: www.womenandhiv.org
The National HIV/AIDS Clinicians’ Consultation Center at the University of California –San Francisco 
maintains an online compendium of state HIV testing laws that can be a useful resource  
(www.nccc.ucsf.edu).
Location/Overnight Address: National HIV/AIDS Clinicians’ Consultation Center 
UCSF Department of Family and Community Medicine at San Francisco General Hospital
1001 Potrero Ave., Bldg. 20, Ward 22
San Francisco, CA 94110
Mailing Address:
UCSF Box 1365
San Francisco, CA 94143-1365
415-206-8700
Perinatal HIV Hotline: 1-888-448-8765
www.nccc.ucsf.edu
Centers for Disease Control and Prevention
1600 Clifton Road NE
Atlanta, GA 30333
www.cdc.gov/hiv
Downloadable resources for patients are available at  
www.cdc.gov/hiv/resources/brochures/index.htm
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